TAIPEI, Taiwan – July 9, 2025 – As regenerative medicine advances from the laboratory to clinical applications, bridging the gap between development and mass production has become the core challenge for leading biotech companies. Cell Bio Biotechnology, a leading provider of integrated solutions for cell research in Taiwan, today announced it will host three expert seminars at the upcoming BioAsia 2025 exhibition. The event will feature distinguished authorities from SONY, ChemoMetec, and Hyperion Analytical, who will provide forward-thinking perspectives on critical solutions spanning R&D, process optimization, and GMP manufacturing.

With the commercialization of cell therapies and exosomes on the horizon, the industry's demand for process stability, precision, and regulatory compliance has never been higher. To address these needs, Cell Bio Biotechnology has curated a series of back-to-back seminars on the afternoon of July 24 at the TaiNEX 1 exhibition hall. The topics will cover three of the industry's most critical aspects:

1. Precision QC at the Source: Why accurate cell counting is the first step to successful product development.

2. Efficient Characterization: How to perform in-depth analysis of the Critical Quality Attributes (CQAs) of exosomes.

3. Automated GMP Processing: How to achieve high-purity, sterile cell sorting for manufacturing.

"We deeply understand the pain points our clients face when bringing innovative therapies to market," said the General Manager of Cell Bio Biotechnology. "We are honored to welcome top experts from SONY, ChemoMetec, and Hyperion. They will present not just individual products, but a complete, seamlessly integrated workflow philosophy. From foundational cell counting and exosome analysis to the pivotal final step of GMP-grade cell sorting, we aim to provide a comprehensive blueprint to help our partners in Taiwan accelerate their development timelines and secure a competitive edge."

The three seminars will be held sequentially at the same venue, offering attendees a one-stop knowledge feast. Whether you are in early-stage R&D, process development, or preparing for clinical and commercial-scale production, this series promises to deliver unparalleled insights.

Seats are limited. Please stay tuned for detailed agendas and registration information.